Topic Review
Urinary Tract Infection and Microbiome
Urinary tract infection is one of the most common bacterial infections and can cause major burdens, not only to individuals but also to an entire society. Urinary tract infection is not only caused by invading uropathogenic bacteria but also by changes to the uromicrobiome milieu, and interactions with other microbial communities can also contribute. 
  • 283
  • 08 Jun 2023
Topic Review
Urinary Tract Infection
Urinary tract infection (UTI) is a common bacterial infection of the urethra, bladder, ureters, and the kidneys. A diagnosis of a positive UTI is any pathogen with a bacterial load of greater than 100,000 CFU/mL in the urine. A bacterial load under 100,000 CFU/mL is considered a negative UTI result. Escherichia coli (E.coli) is the most common pathogen that infects the urinary tract.
  • 7.4K
  • 10 Aug 2020
Topic Review
Urinary Peptides in Hepatocellular Carcinoma
Analysis of the urine samples was performed by capillary electrophoresis (CE) coupled to mass spectrometry (MS). Peptide sequences were obtained and 31 specific peptide markers for hepatocellular carcinoma (HCC) were identified and further integrated into a multivariate classification model. The discovered urinary peptides offered a potential noninvasive tool for diagnosis and prognosis of hepatocellular carcinoma.  
  • 448
  • 25 Aug 2021
Topic Review
Urinary Peptide and Proteomic Biomarkers in CKD
Biomarker development, improvement, and clinical implementation in the context of kidney disease have been a central focus of biomedical research. Only serum creatinine and urinary albumin excretion are well-accepted biomarkers in kidney disease. With their known blind spot in the early stages of kidney impairment and their diagnostic limitations, there is a need for better and more specific biomarkers. With the rise in large-scale analyses of the thousands of peptides in serum or urine samples using mass spectrometry techniques, hopes for biomarker development are high. Advances in proteomic research have led to the discovery of an increasing amount of potential proteomic biomarkers and the identification of candidate biomarkers for clinical implementation in the context of kidney disease management.
  • 219
  • 08 Jun 2023
Topic Review
Urinary Incontinence
Urinary incontinence (UI), also known as involuntary urination, is any uncontrolled leakage of urine. It is a common and distressing problem, which may have a large impact on quality of life. It has been identified as an important issue in geriatric health care. The term enuresis is often used to refer to urinary incontinence primarily in children, such as nocturnal enuresis (bed wetting). UI is an example of a stigmatized medical condition, which creates barriers to successful management and makes the problem worse. People may be too embarrassed to seek medical help, and attempt to self-manage the symptom in secrecy from others. Pelvic surgery, pregnancy, childbirth, and menopause are major risk factors. Urinary incontinence is often a result of an underlying medical condition but is under-reported to medical practitioners. There are four main types of incontinence: Treatments include pelvic floor muscle training, bladder training, surgery, and electrical stimulation. Behavioral therapy generally works better than medication for stress and urge incontinence. The benefit of medications is small and long term safety is unclear. Urinary incontinence is more common in older women.
  • 1.2K
  • 18 Nov 2022
Topic Review
Urinary EVs in kidney-related diseases
Intercellular communication governs multicellular interactions in complex organisms. A variety of mechanisms exist through which cells can communicate, e.g., cell-cell contact, the release of paracrine/autocrine soluble molecules, or the transfer of extracellular vesicles (EVs). EVs are membrane-surrounded structures released by almost all cell types, acting both nearby and distant from their tissue/organ of origin. In the kidney, EVs are potent intercellular messengers released by all urinary system cells and are involved in cell crosstalk, contributing to physiology and pathogenesis. Moreover, urine is a reservoir of EVs coming from the circulation after crossing the glomerular filtration barrier—or originating in the kidney. Thus, urine represents an alternative source for biomarkers in kidney-related diseases, potentially replacing standard diagnostic techniques, including kidney biopsy. 
  • 470
  • 19 Jul 2021
Topic Review
Urinary Bladder Neuroendocrine Neoplasms
Urinary bladder neuroendocrine neoplasms (NENs) are classified into well-differentiated NENs, small-cell NENs, large-cell NENs, and paragangliomas.
  • 677
  • 13 Jul 2022
Topic Review
Urinary Bladder Cancer
Urinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in significant health care costs.
  • 480
  • 28 Jan 2021
Topic Review
Urinary Biomarkers in Bladder Cancer
Extracellular vesicles (EVs) are small membrane vesicles released by all cells and involved in intercellular communication. Importantly, EVs cargo includes nucleic acids, lipids, and proteins constantly transferred between different cell types, contributing to autocrine and paracrine signaling. In recent years, they have been shown to play vital roles, not only in normal biological functions, but also in pathological conditions, such as cancer. In the multistep process of cancer progression, EVs act at different levels, from stimulation of neoplastic transformation, proliferation, promotion of angiogenesis, migration, invasion, and formation of metastatic niches in distant organs, to immune escape and therapy resistance. Moreover, as products of their parental cells, reflecting their genetic signatures and phenotypes, EVs hold great promise as diagnostic and prognostic biomarkers. Importantly, their potential to overcome the current limitations or the present diagnostic procedures has created interest in bladder cancer (BCa). Indeed, cystoscopy is an invasive and costly technique, whereas cytology has poor sensitivity for early staged and low-grade disease. Several urine-based biomarkers for BCa were found to overcome these limitations.
  • 959
  • 10 Oct 2020
Topic Review
Urinary Biomarkers for Early Diagnosis of Disease
Urinary biomarkers are molecules found in urine that can be used as indicators of certain diseases or health conditions. The presence or absence of these biomarkers can help in the early detection of diseases, allowing for timely intervention and treatment, improving patients outcomes.
  • 311
  • 19 Apr 2023
  • Page
  • of
  • 5496
ScholarVision Creations